|
|
||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||
In Practice 22: 620-626 (2000)
© 2000 British Veterinary Association
1 Veterinary Cardiology at Edinburgh
A GOOD understanding of the underlying pathophysiology is required to enable a sensible approach to the treatment and management of canine dilated cardiomyopathy (DCM). This article describes the mechanisms involved in congestive heart failure associated with DCM, and outlines the options available for treatment and management. An article in the previous issue discussed some of the breed-specific manifestations of canine DCM and the approach to diagnosis (In Practice, October 2000, pp 520-530).
Note:
The British Heart Foundation is currently funding the author's research into the genetics of dilated cardiomyopathy in Newfoundland dogs (BHF PG/98060). The author received funding for research on dilated cardiomyopathy from The Kennel Club Charitable Trust during 1996-1999.
| HOME | CURRENT ISSUE | TABLE OF CONTENTS | ARCHIVE | SEARCH | SUBSCRIPTIONS | EVENTS | FEEDBACK | HELP |